• Joshua D Bernstock, Hannah E Olsen, David Segar, Kevin Huang, Ari D Kappel, Walid Ibn Essayed, Phillip L Pearl, and Joseph R Madsen.
• Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Harvard Medical School, Boston, Massachusetts, USA; Department of Neurosurgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: Jbernstock@partners.org.
• World Neurosurg. 2020 Oct 1; 142: 450-455.

BackgroundAicardi syndrome is a severe neurodevelopmental disorder that occurs primarily in females and is characterized by seizures, agenesis of the corpus callosum, and chorioretinal lacunae, which occur together in the majority of affected individuals. Seizures begin in infancy and tend to progress in intensity and are often refractory to standard multimodal medication treatments.Case DescriptionWe present here a unique case of a 12-year-old girl with partial agenesis of the corpus callosum who underwent a corpus callosotomy for treatment of medically refractory epilepsy. In so doing, we also review the literature with regard to the neurosurgical management of these unique patients.ConclusionsFor the subset of children who present with partial, rather than complete, agenesis of the corpus callosum, corpus callosotomy should be considered as a treatment option to reduce seizure burden.Copyright © 2020 Elsevier Inc. All rights reserved.

14 keywords...

hide…